Competition is likely to ramp up Today, Eli Lilly (LLY +0.87%) looks to be the early leader in the GLP-1 space, as it has been experiencing tremendous growth
CHOSING THE RIGHT PEPTIDE Chose Sermorelin if you want to optimize growth hormone levels naturally, focused on antiaging, improved sleep and gradual wellness improvements
reflects their utility and demand, and there are early indications that they could be effective in other therapeutic areas
14 A calculator to assess cardiovascular disease risk in people with type 2 diabetes is available here: Clinical scenarios where empagliflozin or dulaglutide are recommended, but not funded The recently released type 2 diabetes management guidelines developed by the New Zealand Society for the Study of Diabetes (NZSSD), and supported by the Ministry of Health, state that while the Special Authority criteria for empagliflozin and GLP-1 receptor agonists ensure access for those at high risk of cardiovascular and renal disease, the funding restriction is not fully consistent with best practice
Zinc also inhibits the phosphatase and tensin homolog (PTEN), which normally dephosphorylates PIP 3 , thereby suppressing the activation of Akt
